✦ LIBER ✦
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
✍ Scribed by de Rooij, M. F. M.; Kuil, A.; Geest, C. R.; Eldering, E.; Chang, B. Y.; Buggy, J. J.; Pals, S. T.; Spaargaren, M.
- Book ID
- 115454501
- Publisher
- American Society of Hematology
- Year
- 2012
- Tongue
- English
- Weight
- 504 KB
- Volume
- 119
- Category
- Article
- ISSN
- 0006-4971
No coin nor oath required. For personal study only.